In what can be seen as a glimmer of hope in grim times, a vaccine developed jointly by the Jenner Institute at the University of Oxford and drug manufacturer AstraZeneca has shown positive results in human trials.
Called AZD1222, a billion doses of the vaccine will be acquired by the Serum Institute of India for low and middle income countries.
Meanwhile, the Delhi Sero Survey revealed that over 23% of the national capital's population had been exposed to Covid-19.
The survey that was conducted between June 27th and July 10th indicates that a large number of those infected remain asymptomatic.
Top stories with Vikram Chandra
